News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
First data showing overall survival benefit for PARPi maintenance for Ovarian Cancer – ACS Journal Cancer
Photo taken from ACS Journal Cancer/X
Dec 27, 2023, 13:21

First data showing overall survival benefit for PARPi maintenance for Ovarian Cancer – ACS Journal Cancer

ACS Journal Cancer posted on X/Twitter:

“Just published! ‘Top advances of the year: Ovarian Cancer’ by Dr. Melissa Lumish and Dr. William P. Tew of Team Ovary, Memorial Sloan Kettering Cancer Center.

Key updates:

  • Mirvetuximab for PROC
  • First data showing overall survival benefit for PARPi maintenance.”

Further reading.
Source: ACS Journal Cancer/X

ACS Journal Cancer cancer Melissa Lumish Memorial Sloan Kettering Cancer Center Mirvetuximab OncoDaily Oncology Ovarian Cancer PARPi PROC William P. Tew
Special Coverage
Blog
Feb 22, 2025, 04:54
Rick Dean is stepping down as the CEO of OncoHealth
Blog
Feb 22, 2025, 04:49
Wafaa Rashed: Advancing Ethical and Evidence-Based Policy in Genomics
Blog
Feb 22, 2025, 04:42
Jessica Schubel: I'm launching my very own health care and aging policy consulting firm - Day One Strategies
Blog
Feb 22, 2025, 04:37
Karen Knudsen: Honored to be part of the Moffitt Cancer Center External Advisory Committee
Blog
Feb 22, 2025, 04:33
SPCC announced the upcoming launch of the "Digital Oncology" book series
Blog
Feb 22, 2025, 04:29
Results from the SIOPE OCEAN project are out
Blog
Feb 22, 2025, 04:25
Empower families to face their cancer journey with strength and hope - Cancer Hope Network
Blog
Feb 22, 2025, 04:19
Secure your spot for the CCI4EU Online Course by ESO
Blog
Feb 22, 2025, 04:16
Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED
Blog
Feb 22, 2025, 04:12
Citrus Oncology is part of the 14 startups selected for the 2025 CancerX Accelerator
Science
Feb 22, 2025, 04:08
Anticancer potential of NO-Donor Oxadiazole in malignant pleural mesothelioma - The Babak Lab
Blog
Feb 22, 2025, 03:56
Early bird registration deadline for the 15th CCI Europe Conference approaches